Literature DB >> 7627700

Lipoprotein lipase mass and activity in plasma and their increase after heparin are separate parameters with different relations to plasma lipoproteins.

P Tornvall1, G Olivecrona, F Karpe, A Hamsten, T Olivecrona.   

Abstract

Lipoprotein lipase (LPL) activity and mass in plasma and their increase after heparin administration were measured in 61 men who had suffered myocardial infarction before the age of 45 years and in 69 population-based age- and sex-matched control subjects without coronary heart disease to study the relations between these parameters in plasma and their correlations with plasma lipoproteins in subjects with a wide range of lipoprotein and LPL levels. There was a relatively large amount of LPL protein compared with LPL activity in preheparin plasma, indicating that the majority of circulating LPL is catalytically inactive. LPL mass and activity in postheparin plasma (postheparin minus preheparin values) were highly correlated, and the calculated mean specific activity (0.35 mU/ng) was in the range expected for catalytically active LPL. Hence, heparin releases mainly active LPL. The four LPL parameters (mass and activity in plasma and their increase after heparin administration) were not related to each other, except for postheparin plasma LPL mass and activity, and they showed different correlations with plasma lipoprotein lipid concentrations. There was a strong positive correlation between LPL mass in preheparin plasma and the HDL cholesterol level as well as weak negative relations to VLDL triglyceride and cholesterol concentrations in the patients. In contrast, preheparin LPL activity showed no correlation with the HDL cholesterol level but weak positive relations to VLDL triglyceride and cholesterol concentrations in the control subjects.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7627700     DOI: 10.1161/01.atv.15.8.1086

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  26 in total

1.  Pancreatitis may occur with a normal amylase concentration in hypertriglyceridaemia.

Authors:  P Sharma; S Lim; D James; R T Orchard; M Horne; C A Seymour
Journal:  BMJ       Date:  1996-11-16

2.  Insulin sensitisation affects lipoprotein lipase transport in type 2 diabetes: role of adipose tissue and skeletal muscle in response to rosiglitazone.

Authors:  G D Tan; G Olivecrona; H Vidal; K N Frayn; F Karpe
Journal:  Diabetologia       Date:  2006-08-01       Impact factor: 10.122

3.  The tissue distribution of lipoprotein lipase determines where chylomicrons bind.

Authors:  Roger Savonen; Michaela Hiden; Magnus Hultin; Rudolf Zechner; Sanja Levak-Frank; Gunilla Olivecrona; Thomas Olivecrona
Journal:  J Lipid Res       Date:  2015-01-14       Impact factor: 5.922

4.  Lipoprotein lipase activity and interactions studied in human plasma by isothermal titration calorimetry.

Authors:  Mart Reimund; Oleg Kovrov; Gunilla Olivecrona; Aivar Lookene
Journal:  J Lipid Res       Date:  2016-11-14       Impact factor: 5.922

5.  Mutation of conserved cysteines in the Ly6 domain of GPIHBP1 in familial chylomicronemia.

Authors:  Gunilla Olivecrona; Ewa Ehrenborg; Henrik Semb; Elena Makoveichuk; Anna Lindberg; Michael R Hayden; Peter Gin; Brandon S J Davies; Michael M Weinstein; Loren G Fong; Anne P Beigneux; Stephen G Young; Thomas Olivecrona; Olle Hernell
Journal:  J Lipid Res       Date:  2009-12-21       Impact factor: 5.922

6.  Relationships among serum lipoprotein lipase mass, visceral fat, and retinal nerve fiber layer thickness.

Authors:  Chieko Shiba; Tomoaki Shiba; Mao Takahashi; Yuichi Hori; Takatoshi Maeno
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-12-31       Impact factor: 3.117

7.  Increased postprandial triglyceride-rich lipoprotein levels in elderly survivors of myocardial infarction.

Authors:  Samira Lekhal; Trond Børvik; Arne Nordøy; John-Bjarne Hansen
Journal:  Lipids       Date:  2008-04-04       Impact factor: 1.880

Review 8.  Lipoprotein lipase and its role in regulation of plasma lipoproteins and cardiac risk.

Authors:  Jila Kaberi Otarod; Ira J Goldberg
Journal:  Curr Atheroscler Rep       Date:  2004-09       Impact factor: 5.113

9.  Diagnostic value of post-heparin lipase testing in detecting common genetic variants in the LPL and LIPC genes.

Authors:  Mandy van Hoek; Geesje M Dallinga-Thie; Ewout W Steyerberg; Eric J G Sijbrands
Journal:  Eur J Hum Genet       Date:  2009-04-15       Impact factor: 4.246

10.  Lipoprotein lipase activity and mass, apolipoprotein C-II mass and polymorphisms of apolipoproteins E and A5 in subjects with prior acute hypertriglyceridaemic pancreatitis.

Authors:  Inmaculada Coca-Prieto; Pedro Valdivielso; Gunilla Olivecrona; María José Ariza; José Rioja; Pilar Font-Ugalde; Carlota García-Arias; Pedro González-Santos
Journal:  BMC Gastroenterol       Date:  2009-06-17       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.